C-type Lectin DC-SIGN: an Adhesion, Signalling and Antigen-uptake Molecule That Guides Dendritic Cells in Immunity
Overview
Affiliations
The dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a type II C-type lectin whose expression is restricted to the most potent antigen-presenting cells (APCs), the dendritic cells (DCs). In recent years, DC-SIGN has gained an exponential increase in attention because of its involvement in multiple aspects of immune function. Besides being an adhesion molecule, particularly in binding ICAM-2 and ICAM-3, it is also crucial in recognizing several endogenous and exogenous antigens. Additionally, the intracellular domain of DC-SIGN includes molecular motifs, which enable the activation of signal transduction pathways involving Raf-1 and subsequent modulation of DC-maturation status, through direct modification of nuclear factor Nf-kappaB in DCs. Upon DC-SIGN engagement by mannose- or fucose-containing oligosaccharides, the latter leads to a tailored Toll-like receptor signalling, resulting in an altered DC-cytokine profile and skewing of Th1/Th2 responses. In this article, we will discuss recent advances on a broad perspective concerning DC-SIGN structure, signalling and immune function.
Baek H, Yang S, Kim S, Lee Y, Park H, Park M Int J Mol Sci. 2025; 26(5).
PMID: 40076949 PMC: 11901132. DOI: 10.3390/ijms26052329.
Limitations of a proper SFTSV mouse model using human C-type lectin receptors.
Kim Y, Ro H, Lee J, Song Y, Lee H, Cho N Front Microbiol. 2025; 15:1452739.
PMID: 39749135 PMC: 11693710. DOI: 10.3389/fmicb.2024.1452739.
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy.
Huang L, Huang Z, Zhang Y, Lin C, Zhao Z, Li R Theranostics. 2024; 14(14):5528-5550.
PMID: 39310113 PMC: 11413781. DOI: 10.7150/thno.93745.
Tam S, Cheung A, Qin P, Zhang S, Huang Z, Yung K Adv Mater. 2024; 37(2):e2314358.
PMID: 39268785 PMC: 11733713. DOI: 10.1002/adma.202314358.
Nasher F, Wren B Front Microbiol. 2024; 15:1405133.
PMID: 39247694 PMC: 11377244. DOI: 10.3389/fmicb.2024.1405133.